FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Inkeri Elomaa

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Bone Resorption

Phenomena

Nucleic Acid Hybridization

Co-author Network

Publications

TOP 3
Tiina Saarto; Leena Vehmanen; Carl Blomqvist; Inkeri Elomaa
Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer.
Pamela Osterlund; Tarja Ruotsalainen; Riitta Korpela; Maija Saxelin; A Ollus; Päivi Valta; Mauri Kouri; Inkeri Elomaa; Heikki Joensuu
Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study.
Maija Tarkkanen; Marcelo L Larramendy; Tom Böhling; Massimo Serra; Claudia M Hattinger; Aarne Kivioja; Inkeri Elomaa; Piero Picci; Sakari Knuutila
Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistry.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Inkeri Elomaa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Tiina Saarto; Leena Vehmanen; Carl Blomqvist; Inkeri Elomaa
Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(26):4289-95.
2007: Pamela Osterlund; Tarja Ruotsalainen; Riitta Korpela; Maija Saxelin; A Ollus; Päivi Valta; Mauri Kouri; Inkeri Elomaa; Heikki Joensuu
Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study.
British journal of cancer 2007;97(8):1028-34.
2006: Maija Tarkkanen; Marcelo L Larramendy; Tom Böhling; Massimo Serra; Claudia M Hattinger; Aarne Kivioja; Inkeri Elomaa; Piero Picci; Sakari Knuutila
Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistry.
European journal of cancer (Oxford, England : 1990) 2006;42(8):1172-80.
2006: Heikki Joensuu; Pirkko Kellokumpu-Lehtinen; Petri Bono; Tuomo Alanko; Vesa Kataja; Raija Asola; Tapio Utriainen; Riitta Kokko; Akseli Hemminki; Maija Tarkkanen; Taina Turpeenniemi-Hujanen; Sirkku Jyrkkiö; Martti Flander; Leena Helle; Seija Ingalsuo; Kaisu Johansson; Anna-Stina Jääskeläinen; Marjo Pajunen; Mervi Rauhala; Jaana Kaleva-Kerola; Tiina Salminen; Mika Leinonen; Inkeri Elomaa; Jorma Isola
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.
The New England journal of medicine 2006;354(8):809-20.
2006: Leena Vehmanen; Inkeri Elomaa; Carl Blomqvist; Tiina Saarto
Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(4):675-80.
2005: Tiina Saarto; T Taube; Carl Blomqvist; Leena Vehmanen; Inkeri Elomaa
Three-year oral clodronate treatment does not impair mineralization of newly formed bone--a histomorphometric study.
Calcified tissue international 2005;77(2):84-90.
2005: Sirpa Leppä; Tiina Saarto; Leena Vehmanen; Carl Blomqvist; Inkeri Elomaa
Clodronate treatment influences MMP-2 associated outcome in node positive breast cancer.
Breast cancer research and treatment 2005;90(2):117-25.
2004: Timo Joensuu; Tuula Kiviluoto; Päivi Kärkkäinen; Pälvi Vento; Leena Kivisaari; Mikko Tenhunen; Ronny Westberg; Inkeri Elomaa
Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer.
International journal of radiation oncology, biology, physics 2004;60(2):444-52.
2004: Leena Vehmanen; Tiina Saarto; Juha Risteli; Leila Risteli; Carl Blomqvist; Inkeri Elomaa
Short-term intermittent intravenous clodronate in the prevention of bone loss related to chemotherapy-induced ovarian failure.
Breast cancer research and treatment 2004;87(2):181-8.
2004: Leena Vehmanen; Tiina Saarto; Carl Blomqvist; M-R Taskinen; Inkeri Elomaa
Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids.
British journal of cancer 2004;91(3):476-81.
2004: Pamela Osterlund; Tarja Ruotsalainen; Katri Peuhkuri; Riitta Korpela; Anneli Ollus; Minna Ikonen; Heikki Joensuu; Inkeri Elomaa
Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancer.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(8):696-703.
2004: Sirpa Leppä; Tiina Saarto; Leena Vehmanen; Carl Blomqvist; Inkeri Elomaa
A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):1057-63.
2003: Inkeri Elomaa; H Joensuu; C Blomqvist
Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(5):699-703.
2003: Inkeri Elomaa; Heikki Joensuu; Carl Blomqvist
Vinorelbine, epirubicin and fluorouracil as first-line therapy in metastatic breast cancer--a phase II trial.
Acta oncologica (Stockholm, Sweden) 2003;42(4):309-14.
2002: Pamela Osterlund; Arto Orpana; Inkeri Elomaa; Heikki Repo; Heikki Joensuu
Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinoma.
British journal of cancer 2002;87(6):591-9.
2001: Leena Vehmanen; Tiina Saarto; Inkeri Elomaa; Pia Mäkelä; M Välimäki; Carl Blomqvist
Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment.
European journal of cancer (Oxford, England : 1990) 2001;37(18):2373-8.
2001: Tiina Saarto; Leena Vehmanen; Inkeri Elomaa; M Välimäki; Pia Mäkelä; Carl Blomqvist
The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.
British journal of cancer 2001;84(8):1047-51.
2001: Inkeri Elomaa; Mauri Kouri; Tuula Kiviluoto
[Some light for the prognosis of gastric cancer].
Duodecim; lääketieteellinen aikakauskirja 2001;117(18):1785-7.
2001: Inkeri Elomaa; Tiina Saarto
[Use of clodronate in the adjuvant treatment of breast cancer is questionable for the time being].
Duodecim; lääketieteellinen aikakauskirja 2001;117(10):1021-2.
2001: Pamela Osterlund; Inkeri Elomaa; Pekka Virkkunen; Heikki Joensuu
A phase I study of raltitrexed (Tomudex) combined with carmofur in metastatic colorectal cancer.
Oncology 2001;61(2):113-9.
2001: Tiina Saarto; Carl Blomqvist; Pekka Virkkunen; Inkeri Elomaa
Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):10-7.
2000: M Wolf; Wa'el El-Rifai; Maija Tarkkanen; Juha Kononen; M Serra; Erik Fink Eriksen; Inkeri Elomaa; Anne Kallioniemi; Olli Kallioniemi; Sakari Knuutila
Novel findings in gene expression detected in human osteosarcoma by cDNA microarray.
Cancer genetics and cytogenetics 2000;123(2):128-32.
2000: Inkeri Elomaa; Carl Blomqvist; Gunnar Saeter; Måns Akerman; E Stenwig; Thomas Wiebe; O Björk; Thor A Alvegård
Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol.
European journal of cancer (Oxford, England : 1990) 2000;36(7):875-80.
2000: Inkeri Elomaa
Use of bisphosphonates in skeletal metastasis.
Acta oncologica (Stockholm, Sweden) 2000;39(4):445-54.
2000: Paula Poikonen; Tiina Saarto; Inkeri Elomaa; Heikki Joensuu; Carl Blomqvist
Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients.
European journal of cancer (Oxford, England : 1990) 2000;36(1):43-8.
1999: Björn Skytting; J Szymanska; Yan Aalto; T Lushnikova; Carl Blomqvist; Inkeri Elomaa; Olle Larsson; Sakari Knuutila
Clinical importance of genomic imbalances in synovial sarcoma evaluated by comparative genomic hybridization.
Cancer genetics and cytogenetics 1999;115(1):39-46.
1999: Marcelo L Larramendy; N Mandahl; F Mertens; Carl Blomqvist; Aarne Kivioja; Erkki O Karaharju; J Valle; Tom Böhling; Maija Tarkkanen; A Rydholm; Måns Akerman; Henrik C F Bauer; J P Anttila; Inkeri Elomaa; Sakari Knuutila
Clinical significance of genetic imbalances revealed by comparative genomic hybridization in chondrosarcomas.
Human pathology 1999;30(10):1247-53.
1999: Maija Tarkkanen; S Kiuru-Kuhlefelt; Carl Blomqvist; Gemma Armengol; Tom Böhling; Tauno O Ekfors; Martti Virolainen; P Lindholm; OR Monge; Piero Picci; Sakari Knuutila; Inkeri Elomaa
Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors.
Cancer genetics and cytogenetics 1999;114(1):35-41.
1999: Maija Tarkkanen; Riikka Huuhtanen; Martti Virolainen; Tom Wiklund; Sirpa Asko-Seljavaara; Erkki Tukiainen; M Lepäntalo; Inkeri Elomaa; Sakari Knuutila
Comparison of genetic changes in primary sarcomas and their pulmonary metastases.
Genes, chromosomes & cancer 1999;25(4):323-31.
1999: M Wolf; Maija Tarkkanen; Theo J M Hulsebos; Marcelo L Larramendy; Anne Forus; Ola Myklebost; Lauri A Aaltonen; Inkeri Elomaa; Sakari Knuutila
Characterization of the 17p amplicon in human sarcomas: microsatellite marker analysis.
International journal of cancer. Journal international du cancer 1999;82(3):329-33.
1999: Inkeri Elomaa; Carl Blomqvist; Gunnar Saeter; Mef Nilbert; OR Monge; Thomas Wiebe; Thor A Alvegård
Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience.
Acta orthopaedica Scandinavica. Supplementum 1999;285():69-73.
1999: Yan Aalto; Stig Nordling; Aarne Kivioja; Erkki O Karaharju; Inkeri Elomaa; Sakari Knuutila
Among numerous DNA copy number changes, losses of chromosome 13 are highly recurrent in plasmacytoma.
Genes, chromosomes & cancer 1999;25(2):104-7.
1999: Maija Tarkkanen; Inkeri Elomaa; Carl Blomqvist; Aarne Kivioja; P Kellokumpu-Lehtinen; Tom Böhling; J Valle; Sakari Knuutila
DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma.
International journal of cancer. Journal international du cancer 1999;84(2):114-21.
1998: J Szymanska; M Serra; Björn Skytting; Olle Larsson; Martti Virolainen; Måns Akerman; Maija Tarkkanen; Riikka Huuhtanen; Piero Picci; P Bacchini; Sirpa Asko-Seljavaara; Inkeri Elomaa; Sakari Knuutila
Genetic imbalances in 67 synovial sarcomas evaluated by comparative genomic hybridization.
Genes, chromosomes & cancer 1998;23(3):213-9.
1998: Marcelo L Larramendy; Martti Virolainen; Erkki Tukiainen; Inkeri Elomaa; Sakari Knuutila
Chromosome band 1q21 is recurrently gained in desmoid tumors.
Genes, chromosomes & cancer 1998;23(2):183-6.
1998: Tiina Saarto; Carl Blomqvist; Juha Risteli; Leila Risteli; S Sarna; Inkeri Elomaa
Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients.
British journal of cancer 1998;78(2):240-5.
1998: Pekka Autio; Tiina Saarto; Mikko Tenhunen; Inkeri Elomaa; Juha Risteli; Tapani Lahtinen
Demonstration of increased collagen synthesis in irradiated human skin in vivo.
British journal of cancer 1998;77(12):2331-5.
1998: Maija Tarkkanen; Tom Böhling; Gabriella Gamberi; Paola Ragazzini; M S Benassi; Aarne Kivioja; P Kallio; Inkeri Elomaa; Piero Picci; Sakari Knuutila
Comparative genomic hybridization of low-grade central osteosarcoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1998;11(5):421-6.
1998: Mef Nilbert; Gunnar Saeter; Inkeri Elomaa; OR Monge; Thomas Wiebe; Thor A Alvegård
Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
Acta oncologica (Stockholm, Sweden) 1998;37(4):375-8.
1998: Marcelo L Larramendy; P Majander; Tiina Saarto; Mikko Tenhunen; R Caballín; Inkeri Elomaa; Sakari Knuutila
Radiation therapy for breast cancer and clonal chromosome translocations: a fluorescence in situ hybridization study.
Cancer genetics and cytogenetics 1998;100(1):57-62.
1997: J Szymanska; Martti Virolainen; Maija Tarkkanen; Tom Wiklund; Sirpa Asko-Seljavaara; Erkki Tukiainen; Inkeri Elomaa; Carl Blomqvist; Sakari Knuutila
Overrepresentation of 1q21-23 and 12q13-21 in lipoma-like liposarcomas but not in benign lipomas: a comparative genomic hybridization study.
Cancer genetics and cytogenetics 1997;99(1):14-8.
1997: Marcelo L Larramendy; Maija Tarkkanen; Carl Blomqvist; Martti Virolainen; Tom Wiklund; Sirpa Asko-Seljavaara; Inkeri Elomaa; Sakari Knuutila
Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker.
The American journal of pathology 1997;151(4):1153-61.
1997: Marcelo L Larramendy; J Valle; Maija Tarkkanen; Aarne Kivioja; Erkki O Karaharju; T Salmivalli; Inkeri Elomaa; Sakari Knuutila
No DNA copy number changes in osteochondromas: a comparative genomic hybridization study.
Cancer genetics and cytogenetics 1997;97(1):76-8.
1997: Tiina Saarto; Carl Blomqvist; M Välimäki; Pia Mäkelä; S Sarna; Inkeri Elomaa
Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1341-7.
1997: Gunnar Saeter; Inkeri Elomaa; Y Wahlqvist; Thor A Alvegård; Thomas Wiebe; OR Monge; E Forrestier; OP Solheim
Prognostic factors in bone sarcomas.
Acta orthopaedica Scandinavica. Supplementum 1997;273():156-60.
1997: Gunnar Saeter; Thor A Alvegård; Inkeri Elomaa; Thomas Wiebe; O Björk; Hans Strander; OP Solheim
Chemotherapy for osteosarcoma and Ewing's sarcoma.
Acta orthopaedica Scandinavica. Supplementum 1997;273():120-5.
1997: Marcelo L Larramendy; Maija Tarkkanen; J Valle; Aarne Kivioja; H Ervasti; Erkki O Karaharju; T Salmivalli; Inkeri Elomaa; Sakari Knuutila
Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas.
The American journal of pathology 1997;150(2):685-91.
1997: Timo Kylmälä; T Taube; Teuvo L J Tammela; Leila Risteli; Juha Risteli; Inkeri Elomaa
Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer.
British journal of cancer 1997;76(7):939-42.
1997: Gemma Armengol; Maija Tarkkanen; Martti Virolainen; Anne Forus; J Valle; Tom Böhling; Sirpa Asko-Seljavaara; Carl Blomqvist; Inkeri Elomaa; Erkki O Karaharju; Aarne Kivioja; Martti A Siimes; Erkki Tukiainen; Maria Rosa Caballín; Ola Myklebost; Sakari Knuutila
Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization.
British journal of cancer 1997;75(10):1403-9.
1997: M Wolf; Lauri A Aaltonen; J Szymanska; Maija Tarkkanen; Inkeri Elomaa; Sakari Knuutila
Microsatellite markers as tools for characterization of DNA amplifications evaluated by comparative genomic hybridization.
Cancer genetics and cytogenetics 1997;93(1):33-8.
1997: Tiina Saarto; Carl Blomqvist; M Välimäki; Pia Mäkelä; S Sarna; Inkeri Elomaa
Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens.
British journal of cancer 1997;75(4):602-5.
1997: Tiina Saarto; Carl Blomqvist; Pekka Rissanen; Anssi Auvinen; Inkeri Elomaa
Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer.
British journal of cancer 1997;75(2):301-5.
1996: Tiina Saarto; Carl Blomqvist; Christian Ehnholm; Marja-Riitta Taskinen; Inkeri Elomaa
Effects of chemotherapy-induced castration on serum lipids and apoproteins in premenopausal women with node-positive breast cancer.
The Journal of clinical endocrinology and metabolism 1996;81(12):4453-7.
1996: Maija Tarkkanen; S Nordling; Tom Böhling; Aarne Kivioja; J Karaharju E Szymanska; Inkeri Elomaa; Sakari Knuutila
Comparison of cytogenetics, interphase cytogenetics, and DNA flow cytometry in bone tumors.
Cytometry 1996;26(3):185-91.
1996: H Mäenpää; Carl Blomqvist; Tom Wiklund; T Lehtonen; Inkeri Elomaa
Results of treatment in testicular nonseminoma.
Annals of medicine 1996;28(4):311-4.
1996: Maija Tarkkanen; Lauri A Aaltonen; Tom Böhling; Aarne Kivioja; Erkki O Karaharju; Inkeri Elomaa; Sakari Knuutila
No evidence of microsatellite instability in bone tumours.
British journal of cancer 1996;74(3):453-5.
1996: Inkeri Elomaa; Leila Risteli; M Laakso; R Lahtinen; Pekka Virkkunen; Juha Risteli
Monitoring the action of clodronate with type I collagen metabolites in multiple myeloma.
European journal of cancer (Oxford, England : 1990) 1996;32A(7):1166-70.
1996: Carl Blomqvist; Leila Risteli; Juha Risteli; Pekka Virkkunen; S Sarna; Inkeri Elomaa
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma.
British journal of cancer 1996;73(9):1074-9.
1996: J Szymanska; Maija Tarkkanen; Tom Wiklund; Martti Virolainen; Carl Blomqvist; Sirpa Asko-Seljavaara; Erkki Tukiainen; Inkeri Elomaa; Sakari Knuutila
Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization.
Genes, chromosomes & cancer 1996;15(2):89-94.
1996: Tom Wiklund; Riikka Huuhtanen; Carl Blomqvist; Erkki Tukiainen; Martti Virolainen; Pekka Virkkunen; Sirpa Asko-Seljavaara; J M Björkenheim; Inkeri Elomaa
The importance of a multidisciplinary group in the treatment of soft tissue sarcomas.
European journal of cancer (Oxford, England : 1990) 1996;32A(2):269-73.
1996: Tiina Saarto; Carl Blomqvist; Christian Ehnholm; Marja-Riitta Taskinen; Inkeri Elomaa
Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):429-33.
1996: J Szymanska; Maija Tarkkanen; Tom Wiklund; Martti Virolainen; Carl Blomqvist; Sirpa Asko-Seljavaara; Erkki Tukiainen; Inkeri Elomaa; Sakari Knuutila
Cytogenetic study of extraskeletal mesenchymal chondrosarcoma. A case report.
Cancer genetics and cytogenetics 1996;86(2):170-3.
1996: Carl Blomqvist; Inkeri Elomaa
Bisphosphonate therapy in metastatic breast cancer.
Acta oncologica (Stockholm, Sweden) 1996;35 Suppl 5():81-3.
1996: Tom Wiklund; Carl Blomqvist; Leila Risteli; Juha Risteli; Erkki O Karaharju; Inkeri Elomaa
Type I and type III collagen metabolites in adult osteosarcoma patients.
British journal of cancer 1996;73(1):106-9.
1995: J Szymanska; Maija Tarkkanen; Tom Wiklund; Martti Virolainen; Carl Blomqvist; Sirpa Asko-Seljavaara; Erkki Tukiainen; Inkeri Elomaa; Sakari Knuutila
A cytogenetic study of malignant fibrous histiocytoma.
Cancer genetics and cytogenetics 1995;85(2):91-6.
1995: Timo Kylmälä; Teuvo L J Tammela; Leila Risteli; Juha Risteli; M Kontturi; Inkeri Elomaa
Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.
British journal of cancer 1995;71(5):1061-4.
1995: Tiina Saarto; Carl Blomqvist; K Tiusanen; P Gröhn; P Rissanen; Inkeri Elomaa
The prognosis of stage III breast cancer treated with postoperative radiotherapy and adriamycin-based chemotherapy with and without tamoxifen. Eight year follow-up results of a randomized trial.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(2):146-50.
1995: Carl Blomqvist; Tom Wiklund; M Pajunen; Martti Virolainen; Inkeri Elomaa
Oral trofosfamide: an active drug in the treatment of soft-tissue sarcoma.
Cancer chemotherapy and pharmacology 1995;36(3):263-5.
1995: Inkeri Elomaa; Carl Blomqvist
Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancy.
Acta oncologica (Stockholm, Sweden) 1995;34(5):629-36.
1994: K Porkka; Carl Blomqvist; P Rissanen; Inkeri Elomaa; Seppo Pyrhönen
Salvage therapies in women who fail to respond to first-line treatment with fluorouracil, epirubicin, and cyclophosphamide for advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(8):1639-47.
1994: M Laakso; R Lahtinen; Pekka Virkkunen; Inkeri Elomaa
Subgroup and cost-benefit analysis of the Finnish multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group.
British journal of haematology 1994;87(4):725-9.
1994: T Taube; Inkeri Elomaa; Carl Blomqvist; Monique Beneton; John A Kanis
Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer.
Bone 1994;15(2):161-6.
1994: Maija Tarkkanen; Tom Wiklund; Martti Virolainen; Inkeri Elomaa; Sakari Knuutila
Dedifferentiated chondrosarcoma with t(9;22)(q34;q11-12).
Genes, chromosomes & cancer 1994;9(2):136-40.
1994: T Taube; Timo Kylmälä; Christel Lamberg-Allardt; Teuvo L J Tammela; Inkeri Elomaa
The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study.
European journal of cancer (Oxford, England : 1990) 1994;30A(6):751-8.
1993: Maija Tarkkanen; Erkki O Karaharju; Tom Böhling; J Szymanska; H Heliö; Aarne Kivioja; Inkeri Elomaa; Sakari Knuutila
Chromosome study of 249 patients examined for a bone tumor.
Clinical orthopaedics and related research 1993;(297):117-28.
1993: H Heliö; Aarne Kivioja; Erkki O Karaharju; Inkeri Elomaa; Sakari Knuutila
Malignant fibrous histiocytoma arising in a previous site of fracture and osteomyelitis.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1993;19(5):479-84.
1993: Carl Blomqvist; Tom Wiklund; Maija Tarkkanen; Inkeri Elomaa; Martti Virolainen
Measurement of growth rate of lung metastases in 21 patients with bone or soft-tissue sarcoma.
British journal of cancer 1993;68(2):414-7.
1993: Maija Tarkkanen; A Kaipainen; Erkki O Karaharju; Tom Böhling; J Szymanska; H Heliö; Aarne Kivioja; Inkeri Elomaa; Sakari Knuutila
Cytogenetic study of 249 consecutive patients examined for a bone tumor.
Cancer genetics and cytogenetics 1993;68(1):1-21.
1993: Carl Blomqvist; Inkeri Elomaa; P Rissanen; Päivi S Hietanen; K Nevasaari; L Helle
Influence of treatment schedule on toxicity and efficacy of cyclophosphamide, epirubicin, and fluorouracil in metastatic breast cancer: a randomized trial comparing weekly and every-4-week administration.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):467-73.
1993: Maija Tarkkanen; Tom Böhling; H Heliö; Erkki O Karaharju; A Kaipainen; J Szymanska; Inkeri Elomaa; Sakari Knuutila
A recurrent chondromyxoid fibroma with chromosome aberrations ins(5;2)(q13;p21p25) and 2p deletion: a case report.
Cancer genetics and cytogenetics 1993;65(2):141-6.
1993: Tom Wiklund; Carl Blomqvist; Leila Risteli; Juha Risteli; Inkeri Elomaa
Impact of chemotherapy on collagen metabolism: a study of serum PIIINP (aminoterminal propeptide of type III procollagen) in advanced sarcomas.
Journal of cancer research and clinical oncology 1993;119(3):160-4.
1993: T Taube; Inkeri Elomaa; Carl Blomqvist; Monique Beneton; John A Kanis
Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer: a histomorphometric study.
European journal of cancer (Oxford, England : 1990) 1993;29A(12):1677-81.
1993: Timo Kylmälä; T Tammela; Leila Risteli; Juha Risteli; T Taube; Inkeri Elomaa
Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group.
European journal of cancer (Oxford, England : 1990) 1993;29A(6):821-5.
1992: Carl Blomqvist; K Tiusanen; Inkeri Elomaa; P Rissanen; T Hietanen; E Heinonen; P Gröhn
The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial.
British journal of cancer 1992;66(6):1171-6.
1992: R Lahtinen; M Laakso; I Palva; Pekka Virkkunen; Inkeri Elomaa
Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group.
Lancet 1992;340(8827):1049-52.
1992: T Taube; Kaarle Franssila; Leila Risteli; Juha Risteli; Inkeri Elomaa
Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP).
British journal of haematology 1992;82(1):32-7.
1992: Inkeri Elomaa; Pekka Virkkunen; Leila Risteli; Juha Risteli
Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.
British journal of cancer 1992;66(2):337-41.
1992: Carl Blomqvist; Inkeri Elomaa; P Rissanen
Adjuvant hormone therapy in breast cancer.
Annals of medicine 1992;24(2):91-6.
1992: Tom Wiklund; Inkeri Elomaa; Carl Blomqvist; Leila Risteli; Juha Risteli
Type III collagen metabolism in soft tissue sarcomas.
British journal of cancer 1992;65(2):193-6.
1992: Carl Blomqvist; Inkeri Elomaa; P Rissanen; Päivi S Hietanen; K Nevasaari; L Helle
FEC (5-fluorouracil-epirubicin-cyclophosphamide) monthly versus FEC weekly in metastatic breast cancer. First results of a randomized trial.
Acta oncologica (Stockholm, Sweden) 1992;31(2):231-6.
1992: Tom Wiklund; Carl Blomqvist; Martti Virolainen; Inkeri Elomaa
Ifosfamide, vincristine, doxorubicin and dacarbazine in adult patients with advanced soft-tissue sarcoma.
Cancer chemotherapy and pharmacology 1992;30(2):100-4.
1992: Aarne Kivioja; Erkki O Karaharju; Inkeri Elomaa; Tom Böhling
Surgical treatment of myeloma of bone.
European journal of cancer (Oxford, England : 1990) 1992;28A(11):1865-9.
1992: Inkeri Elomaa; Timo Kylmälä; T Tammela; J Viitanen; J Ottelin; Mirja Ruutu; K Jauhiainen; M Ala-Opas; L Roos; J Seppänen
Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer.
International urology and nephrology 1992;24(2):159-66.
1991: Tom Wiklund; Carl Blomqvist; J Räty; Inkeri Elomaa; P Rissanen; M Miettinen
Postirradiation sarcoma. Analysis of a nationwide cancer registry material.
Cancer 1991;68(3):524-31.
1991: Inkeri Elomaa; P Kellokumpu-Lehtinen; S Rannikko; O Alfthan
Hormone-resistant metastatic prostate cancer. Comparisons between estramustine phosphate and low-dose epirubicin treatments.
European urology 1991;19(1):12-5.
1990: Inkeri Elomaa; M A Siimes; Carl Blomqvist; Erkki O Karaharju; S Ryöppy; E Laasonen; T Holmström
Ten years' experience in patients with osteogenic sarcoma in Finland.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1990;16(2):147-52.
1990: Inkeri Elomaa; M Salmo; L Roos; L Helle; Markku Korpela; S Numminen; M Virén; H Allonen
Aclarubicin in the treatment of advanced gastrointestinal adenocarcinoma.
Acta oncologica (Stockholm, Sweden) 1990;29(5):636-7.
1989: P J Pentikäinen; Inkeri Elomaa; A K Nurmi; S Kärkkäinen
Pharmacokinetics of clodronate in patients with metastatic breast cancer.
International journal of clinical pharmacology, therapy, and toxicology 1989;27(5):222-8.
1989: Inkeri Elomaa; Carl Blomqvist; L Porkka; T Holmström
Experiences of clodronate treatment of multifocal eosinophilic granuloma of bone.
Journal of internal medicine 1989;225(1):59-61.
1988: Inkeri Elomaa; T Taube; Carl Blomqvist; P Rissanen; Sakari Rannikko; O Alfthan
Aminoglutethimide for advanced prostatic cancer resistant to conventional hormonal therapy.
European urology 1988;14(2):104-6.
1988: Carl Blomqvist; Inkeri Elomaa; L Porkka; Sirkka-Liisa Karonen; Christel Lamberg-Allardt
Evaluation of salmon calcitonin treatment in bone metastases from breast cancer--a controlled trial.
Bone 1988;9(1):45-51.
1988: Inkeri Elomaa; Carl Blomqvist; P Rissanen
Weekly low-dose doxorubicin as second line therapy in advanced breast cancer.
Acta oncologica (Stockholm, Sweden) 1988;27(6b):799-801.
1988: Inkeri Elomaa; Carl Blomqvist; L Porkka; T Holmström; T Taube; Christel Lamberg-Allardt; G H Borgström
Clodronate for osteolytic metastases due to breast cancer.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1988;42(2):111-6.
1988: Inkeri Elomaa; Carl Blomqvist; P Rissanen; Matti Mäntylä
Weekly low-dose doxorubicin with or without high-dose medroxyprogesterone acetate as secondary treatment in metastatic breast cancer--a randomized trial.
Acta oncologica (Stockholm, Sweden) 1988;27(3):297-9.
1987: Carl Blomqvist; Inkeri Elomaa; Pekka Virkkunen; L Porkka; Sirkka-Liisa Karonen; L Risteli; Juha Risteli
The response evaluation of bone metastases in mammary carcinoma. The value of radiology, scintigraphy, and biochemical markers of bone metabolism.
Cancer 1987;60(12):2907-12.
1987: Inkeri Elomaa; Carl Blomqvist; L Porkka; Christel Lamberg-Allardt; G H Borgström
Treatment of skeletal disease in breast cancer: a controlled clodronate trial.
Bone 1987;8 Suppl 1():S53-6.
1987: M Ala-Opas; Inkeri Elomaa; L Porkka; O Alfthan
Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stones.
Scandinavian journal of urology and nephrology 1987;21(4):311-4.
1987: G H Borgström; Inkeri Elomaa; Carl Blomqvist; L Porkka
Cytogenetic investigations of patients on clodronate therapy for Paget's disease of bone.
Bone 1987;8 Suppl 1():S85-6.
1985: Inkeri Elomaa; Carl Blomqvist; L Porkka; T Holmström; T Taube; Christel Lamberg-Allardt; G H Borgström
Diphosphonates for osteolytic metastases.
Lancet 1985;1(8438):1155-6.
1984: Inkeri Elomaa; M Ala-Opas; L Porkka
Five years of experience with selective therapy in recurrent calcium nephrolithiasis.
The Journal of urology 1984;132(4):656-61.
1984: Inkeri Elomaa; Carl Blomqvist; L Porkka; T Holmström; H Laine
Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism.
Cancer treatment reports 1984;68(4):655-7.
1983: Inkeri Elomaa; Carl Blomqvist; P Gröhn; L Porkka; A L Kairento; K Selander; Christel Lamberg-Allardt; T Holmström
Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.
Lancet 1983;1(8317):146-9.